TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $427 | -10.5% | 27,596 | -9.1% | 0.00% | 0.0% |
| Q2 2023 | $477 | -16.2% | 30,356 | -12.2% | 0.00% | 0.0% |
| Q1 2023 | $569 | +4.0% | 34,576 | -1.5% | 0.00% | 0.0% |
| Q4 2022 | $547 | -99.9% | 35,106 | -46.7% | 0.00% | -50.0% |
| Q3 2022 | $854,000 | -10.5% | 65,857 | -3.1% | 0.00% | 0.0% |
| Q2 2022 | $954,000 | -12.4% | 67,990 | -10.6% | 0.00% | 0.0% |
| Q1 2022 | $1,089,000 | +0.9% | 76,071 | -3.9% | 0.00% | 0.0% |
| Q4 2021 | $1,079,000 | -45.6% | 79,174 | -34.6% | 0.00% | -60.0% |
| Q3 2021 | $1,983,000 | -30.7% | 121,067 | -28.8% | 0.01% | -28.6% |
| Q2 2021 | $2,862,000 | +12.9% | 170,096 | +22.5% | 0.01% | 0.0% |
| Q1 2021 | $2,534,000 | +43.4% | 138,807 | +42.9% | 0.01% | +40.0% |
| Q4 2020 | $1,767,000 | +265.8% | 97,133 | +258.5% | 0.01% | +150.0% |
| Q3 2020 | $483,000 | -10.9% | 27,094 | -10.4% | 0.00% | 0.0% |
| Q2 2020 | $542,000 | +12.7% | 30,246 | -4.7% | 0.00% | 0.0% |
| Q1 2020 | $481,000 | -31.7% | 31,736 | -11.1% | 0.00% | -33.3% |
| Q4 2019 | $704,000 | +20.8% | 35,695 | +5.2% | 0.00% | +50.0% |
| Q3 2019 | $583,000 | +28.7% | 33,928 | +32.5% | 0.00% | 0.0% |
| Q2 2019 | $453,000 | -37.4% | 25,600 | -28.0% | 0.00% | -33.3% |
| Q1 2019 | $724,000 | – | 35,567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |